© 2023 by Hunter & Thompson. Proudly created with Wix.com

The Campbell Lab

The aim of the Campbell lab is the characterisation of chemokines and chemokine receptor expression in cells clinically to better advise their use applications such as cell therapy and organ transplantation.


Dr. Kay Hewit

About Kay

I am a research scientist within the Advanced Therapeutics department of the Scottish National Blood Transfusion Service (SNBTS) and I work in collaboration with the CRG. My primary project is concerned with increasing our understanding of mesenchymal stromal cells (MSCs), and in particular, their potential to be used in cell therapy due to their immunomodulatory and anti-inflammatory properties. I am using CRISPR technology on MSCs in order to knock out key genes of interest, including chemokines and their receptors, in order to understand their function in these cells. My role also involves the development and optimization of CRISPR as a core technique to be used frequently within the CRG.

Contact by email

Dr Alan Hayes

About Alan

Contact by email

Chris Kelly

About Chris

Contact by email

Ph.D. Students

Nerea Cuesta Gomez

About Nerea

My PhD is focused on studying the effect of the manipulation of chemokine and chemokine receptor genes in Mesenchymal Stromal Cells (MSCs) so as to enhance engraftment of cellular therapeutics. Moreover, I am interested in the effect of the tumour suppressor p53 in the regulation of the MSCs and its relevance for the clinic.


Contact by email